Skip to main content

Advertisement

Log in

Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts

  • Ideas and Technical Innovations
  • Published:
European Spine Journal Aims and scope Submit manuscript

Abstract

Introduction

Aneurysmal bone cysts (ABCs) are expansive and destructive lesions positive for osteoclast markers, resembling benign giant cell tumors (GCTs). Treatment options include surgical resection, curettage and cavity filling, embolization, injection of fibrosing agents, or radiotherapy. Particularly in children and adolescents with spinal ABCs, these options may be unsatisfactory, and innovative forms of treatment are needed. Denosumab is a human monoclonal antibody that inhibits osteoclast function by blocking the cytokine receptor activator of the nuclear factor-kappa B ligand. Satisfactory results with denosumab in treating GCTs and immunohistochemical similarities suggest that it may also have positive effects on ABCs.

Methods and Results

This report is the first description of the therapeutic use of denosumab in two patients with spinal ABCs. Two boys (aged 8 and 11) had recurrent ABCs at C5 after surgery with intralesional tumor resection. Treatment options were discussed by the interdisciplinary tumor board. Arterial embolization was attempted, but failed due to an absence of appropriate afferent arteries. After the families had received extensive information and provided written consent, denosumab therapy was initiated as an individualized treatment, despite the absence as yet of scientific evidence. After the start of denosumab therapy, both patients recovered from pain and neurologic symptoms significantly and are now in a healthy condition with no severe side effects. Magnetic resonance imaging check-ups after 2 or 4 months of denosumab treatment, respectively, showed tumor regression in both patients.

Discussion

Longer follow-up and clinical studies are warranted to establish the value of denosumab in the treatment of ABCs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Balke M, Henrichs MP, Gosheger G, Ahrens H, Streitbuerger A, Koehler M, Bullmann V, Hardes J (2012) Giant cell tumors of the axial skeleton. Sarcoma 2012:410973

    Article  PubMed  Google Scholar 

  2. Boriani S, De Iure F, Campanacci L, Gasbarrini A, Bandiera S, Biagini R, Bertoni F, Picci P (2001) Aneurysmal bone cyst of the mobile spine: report on 41 cases. Spine (Phila Pa 1976) 26:27–35

    Article  CAS  Google Scholar 

  3. Branstetter DG, Nelson SD, Manivel JC, Blay JY, Chawla S, Thomas DM, Jun S, Jacobs I (2012) Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone. Clin Cancer Res 18:4415–4424

    Article  PubMed  CAS  Google Scholar 

  4. Dubousset J (1980) Spine deformities induced by irradiation of Wilm’s tumors (author’s transl). Rev Chir Orthop Reparatrice Appar Mot 66:441–451. French

    Google Scholar 

  5. Feigenberg SJ, Marcus RB Jr, Zlotecki RA, Scarborough MT, Berrey BH, Enneking WF (2001) Megavoltage radiotherapy for aneurysmal bone cysts. Int J Radiat Oncol Biol Phys 49:1243–1247

    Article  PubMed  CAS  Google Scholar 

  6. Koswig S, Budach V (2002) The role of radiotherapy in the treatment of bone neoplasms. Chirurg 73:1174–1180 German

    Article  PubMed  CAS  Google Scholar 

  7. Lim JB, Sharma H, Reid R, Reece AT (2012) Aneurysmal bone cysts of the vertebrae. J Orthop Surg (Hong Kong) 20:201–204

    Google Scholar 

  8. Lipton A, Fizazi K, Stopeck AT, Henry DH, Brown JE, Yardley DA, Richardson GE, Siena S, Maroto P, Clemens M, Bilynskyy B, Charu V, Beuzeboc P, Rader M, Viniegra M, Saad F, Ke C, Braun A, Jun S (2012) Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials. Eur J Cancer 48:3082–3092

    Article  PubMed  CAS  Google Scholar 

  9. Liu JK, Brockmeyer DL, Dailey AT, Schmidt MH (2003) Surgical management of aneurysmal bone cysts of the spine. Neurosurg Focus 15:E4

    PubMed  Google Scholar 

  10. Marushima A, Matsumaru Y, Suzuki K, Takigawa T, Kujiraoka Y, Anno I, Matsumura A (2009) Selective arterial embolization with n-butyl cyanoacrylate in the treatment of aneurysmal bone cyst of the thoracic vertebra: a case report. Spine (Phila Pa 1976) 34:E230–E234

    Article  Google Scholar 

  11. Miller PD (2011) A review of the efficacy and safety of denosumab in postmenopausal women with osteoporosis. Ther Adv Musculoskelet Dis 3:271–282

    Article  PubMed  CAS  Google Scholar 

  12. Papagelopoulos PJ, Currier BL, Shaughnessy WJ, Sim FH, Ebsersold MJ, Bond JR, Unni KK (1998) Aneurysmal bone cyst of the spine management and outcome. Spine (Phila Pa 1976) 23:621–628

    Article  CAS  Google Scholar 

  13. Rapp TB, Ward JP, Alaia MJ (2012) Aneurysmal bone cyst. J Am Acad Orthop Surg 20:233–241

    Article  PubMed  Google Scholar 

  14. Shisha T, Marton-Szucs G, Dunay M, Pap K, Kiss S, Nemeth T, Szendrõi M, Szoke G (2007) The dangers of intraosseous fibrosing agent injection in the treatment of bone cysts. The origin of major complications shown in a rabbit model. Int Orthop 31:359–362

    Article  PubMed  CAS  Google Scholar 

  15. Silva-Fernández L, Rosario MP, Martínez-López JA, Carmona L, Loza E (2012) Denosumab for the treatment of osteoporosis: A systematic literature review. Reumatol Clin 2012 Sep 1. [Epub ahead of print]

  16. Thomas D (2010) Denosumab in the treatment of giant cell tumor of bone. US Oncol Rev 6:39–41

    Google Scholar 

  17. Thomas D, Carriere P, Jacobs I (2010) Safety of denosumab in giant-cell tumour of bone. Lancet Oncol 11:815

    Article  PubMed  Google Scholar 

  18. Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, Roudier M, Smith J, Ye Z, Sohn W, Dansey R, Jun S (2010) Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 11:275–280

    Article  PubMed  CAS  Google Scholar 

  19. Won KY, Kalil RK, Kim YW, Park YK (2011) RANK signalling in bone lesions with osteoclast-like giant cells. Pathology 43:318–321

    Article  PubMed  Google Scholar 

  20. Zenonos G, Jamil O, Governale LS, Jernigan S, Hedequist D, Proctor MR (2012) Surgical treatment for primary spinal aneurysmal bone cysts: experience from Children’s Hospital Boston. J Neurosurg Pediatr 9:305–315

    Article  PubMed  Google Scholar 

  21. Zileli M, Isik HS, Ogut FE, Is M, Cagli S, Calli C (2012) Aneurysmal bone cysts of the spine. Eur Spine J Oct 1 [Epub ahead of print]

Download references

Acknowledgments

The authors especially thank Sebastian Retzlaff, MD, for contributing the MRI of patient no. 2.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tobias Lange.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lange, T., Stehling, C., Fröhlich, B. et al. Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts. Eur Spine J 22, 1417–1422 (2013). https://doi.org/10.1007/s00586-013-2715-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00586-013-2715-7

Keywords

Navigation